Cell based assay procedure is gaining rapid demand across the medical sector. This process is defined by the analysis of live cell, which is used in various commercial and research based applications. These methods are emerging as one of the most preferred tools amongst different methods like biochemical assays and animal tests. Increased reliability and advancements in this technology are some of the major drivers for the global cell based assay market. The industry is witnessing steady influx in terms of business, revenue and demand from different avenues like basic medical research, predictive toxicology and drug discovery. The high input rate and accurate results are expected to drive more demand and business opportunities for this industry in the coming future.
Segments in Cell-Based Assays Industry
The global industry is segmented into different types of products, their applications, market volumes of different instruments, customizability, types of end-users and regional demand. The products segments are mainly divided into reagents and assay kits, instruments, services, software programs and automation instruments. Basic applications of these methods include in ADME studies, drug discovery, predictive toxicology, basic research and other applications. Screening and detection instruments included in the research include flow cytometers, microplate readers, fluorescent microscopes, label-free detection instruments, and high content screening instruments. Major end users for these products include government and academic institutes, CROs, pharma and biotechnology institutes and so on.
Drivers and Restraints
The global cell based assay market is strongly driven by four major driving factors, which include significant advantage of these methods over the conventional methods. This fact makes the cell-based assay methods highly reliable in terms of commercial and research applications. Growth in drug discovery activities and implementation of HTS and automation techniques are also driving this industry at a healthy growth rate. Growth in the private-public partnerships and positive help from governments in terms of funding are expected to create strong demand in the global market. Three major restraints for the industry include skepticism about the long term benefits of this technique, shortage of skilled experts and issues of intellectual property rights.
Trends and Forecasts
The global market is seeking growth opportunities from the rising demand in Asian markets, development of high content screening and software and use of stem cell and 3D culture techniques. Label-free technologies are also expected to create strong rise in demand for the industry. According to the latest research reports, the global cell based assay market is expected to grow at a CAGR of 11.1% from 2013 to 2018. At the projected growth rate, the industry is set to become worth more than $14.8 billion by the end of the year 2018. Rapid developments across cell biology, bioinformatics, proteomics and genomics are expected to create exciting business opportunities in the market.